Gary E. Archer

8.6k citations
80 papers · 6.6k · 1 hit paper · h-index 42

Impact in

  • Genetics top 0.2%
    • Glioma Diagnosis and Treatment
    • Virus-based gene therapy research
  • Immunology top 0.5%
    • Immunotherapy and Immune Responses
    • Immune Cell Function and Interaction

Papers in

    • CAR-T cell therapy research 22
    • Cancer Immunotherapy and Biomarkers 13
    • HER2/EGFR in Cancer Research 6
    • Immunotherapy and Immune Responses 31
    • T-cell and B-cell Immunology 6

Gary E. Archer

79 papers receiving 6.5k citations

Gary E. Archer's Hit Papers

Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma 2010 · 615 citations
6150+5+10Years since publication200400600

Peers

Gary E. Archer
Comparison fields: 5 of 100
  • Genetics 2.2k
  • Immunology 2.8k
  • Oncology 3.2k
  • Radiology, Nuclear Medicine and Imaging 808
  • Cancer Research 408
Replace Hideho Okada with:
Hideho Okada United States
Carol J. Wikstrand United States
Hiroaki Wakimoto United States
Luis Sánchez-Pérez United States
Peter Kufer Germany
Gary Kohanbash United States
Barbara Murdoch Canada
Michael A. Curran United States
Magnus Essand Sweden
Lisa Sevenich Germany
Gary E. Archer relative to Hideho Okada United States Hideho Okada's profile →
Citations per field
00.5×1.5×2.5×
Hideho Okada · 1×
Citations per year

Countries citing papers authored by Gary E. Archer

Since Specialization
Citations

This map shows the geographic impact of Gary E. Archer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary E. Archer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary E. Archer more than expected).

Fields of papers citing papers by Gary E. Archer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary E. Archer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary E. Archer. The network helps show where Gary E. Archer may publish in the future.

Co-authors

The 25 scholars most cited alongside Gary E. Archer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gary E. Archer Line = papers co-authored together Gary E. Archer links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 80 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Immunologic Escape After Prolonged Progression-Free Survival With Epidermal Growth Factor Receptor Variant III Peptide Vaccination in Patients With Newly Diagnosed Glioblastoma
Hit paper breakdown →
2010615
2 2006471
3 2015414
4 1990303
5 2007267
6 2017246
7 2009222
8
Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion.
2002212
9 2009202
10
Epidermal growth factor receptor VIII peptide vaccination is efficacious against established intracerebral tumors.
2003193
11 1996181
12 2000149
13 1998140
14
Brain tumors in mice are susceptible to blockade of epidermal growth factor receptor (EGFR) with the oral, specific, EGFR-tyrosine kinase inhibitor ZD1839 (iressa).
2002138
15 2004131
16 2008126
17 2000113
18 2012112
19 2009108
20 2008108

About Gary E. Archer

Gary E. Archer is a scholar working on Oncology, Immunology, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Genetics, having authored 80 papers that have together received 6.6k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (31 papers), CAR-T cell therapy research (22 papers), Monoclonal and Polyclonal Antibodies Research (14 papers), Cancer Immunotherapy and Biomarkers (13 papers), Glioma Diagnosis and Treatment (13 papers), T-cell and B-cell Immunology (6 papers), HER2/EGFR in Cancer Research (6 papers) and Radiopharmaceutical Chemistry and Applications (6 papers). The work is most often cited by research in Genetics (2.2k citations), Immunology (2.8k citations), Oncology (3.2k citations), Radiology, Nuclear Medicine and Imaging (808 citations) and Cancer Research (408 citations). Gary E. Archer has collaborated with scholars based in United States, Australia and Germany. Frequent co-authors include Darell D. Bigner, John H. Sampson, Duane A. Mitchell, Allan H. Friedman, Henry S. Friedman, James E. Herndon, Amy B. Heimberger, Roger E. McLendon, Michael R. Zalutsky and Glenn Dranoff. Their work appears in journals such as Clinical Cancer Research, Journal of Clinical Oncology, Proceedings of the National Academy of Sciences, Neurosurgery and Journal of Neuroimmunology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact